About This Course
The last few years have brought several new therapeutic options into the world of COPD, with even more on the horizon. This webinar examines current best practices for managing COPD symptoms, including pharmacologic and non-pharmacologic options, and provides insights into designing the optimal treatment plan for your patient.
Presenter
Michael W. Hess, MPH, RRT, RPFT, Senior Director of Advocacy and Regulatory Affairs, COPD Foundation.
This session is supported through unrestricted educational grants secured by AARC. All content was developed and delivered independently.
This activity was supported through grants from Verona Pharma, Viatris, Takeda, Grifols, Olympus, and Linde.
Participants will be able to explain the indications and contraindications for oxygen therapy and inhaled corticosteroids in COPD.
Participants will be able to recommend appropriate pharmacological interventions for COPD patients, based on the severity of their disease and the presence of comorbidities.
Participants will be able to develop a comprehensive pulmonary rehabilitation plan for COPD patients, tailored to their individual needs and goals.
Participants will be able to select the most appropriate bronchodilator for a given COPD patient, considering their symptoms and disease severity.
Participants will be able to evaluate the risks and benefits of LABAs and LAMAs in COPD management.
Approved CRCE Hours
1.00
Category
Advertisement